Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 1998; Volume 26,Issue 9

SYMPOSIUM

  • You have access
    The N-Glucuronidation of Xenobiotics
    Ronald B. Franklin
    Drug Metabolism and Disposition September 1998, 26 (9) 829;
  • You have access
    N +-Glucuronidation, a Common Pathway in Human Metabolism of Drugs With a Tertiary Amine Group
    Edward M. Hawes
    Drug Metabolism and Disposition September 1998, 26 (9) 830-837;
  • You have access
    Species Differences in N-Glucuronidation
    Shuet-Hing Lee Chiu and Su-Er W. Huskey
    Drug Metabolism and Disposition September 1998, 26 (9) 838-847;
  • You have access
    Olanzapine 10-N-Glucuronide
    Kelem Kassahun, Edward Mattiuz, Ronald Franklin and Todd Gillespie
    Drug Metabolism and Disposition September 1998, 26 (9) 848-855;
  • You have access
    N-Glucuronidation of Benzidine and Its Metabolites
    Terry V. Zenser, Vijaya M. Lakshmi and Bernard B. Davis
    Drug Metabolism and Disposition September 1998, 26 (9) 856-859;
  • You have access
    Glucuronidation of Amine Substrates by Purified and Expressed UDP-Glucuronosyltransferase Proteins
    Mitchell D. Green and Thomas R. Tephly
    Drug Metabolism and Disposition September 1998, 26 (9) 860-867;

Articles

  • You have access
    Human Cytochrome P450–Catalyzed Conversion of the Proestrogenic Pesticide Methoxychlor Into an Estrogen
    David M. Stresser and David Kupfer
    Drug Metabolism and Disposition September 1998, 26 (9) 868-874;
  • You have access
    Interaction of Terfenadine and Its Primary Metabolites with Cytochrome P450 2D6
    Barry C. Jones, Ruth Hyland, Mark Ackland, Christine A. Tyman and Dennis A. Smith
    Drug Metabolism and Disposition September 1998, 26 (9) 875-882;
  • You have access
    Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy
    C. Aeschlimann, A. Küpfer, H. Schefer and T. Cerny
    Drug Metabolism and Disposition September 1998, 26 (9) 883-890;
  • You have access
    Metabolism of Clenbuterol in Rats
    Daniel Zalko, Laurent Debrauwer, Georges Bories and Jacques Tulliez
    Drug Metabolism and Disposition September 1998, 26 (9) 891-899;
  • You have access
    Deposition and Retention of Radiolabeled Serum Constituents in Hair After Systemic Administration
    Peter R. Stout, Donna Dehn and James A. Ruth
    Drug Metabolism and Disposition September 1998, 26 (9) 900-906;
  • You have access
    In Vivo Metabolism and Disposition of the Nephrotoxicant N-(3,5-Dichlorophenyl)succinimide in Fischer 344 Rats
    Robert J. Griffin and Peter J. Harvison
    Drug Metabolism and Disposition September 1998, 26 (9) 907-913;
  • You have access
    Metabolism of 3-Butene-1,2-diol in B6C3F1 Mice
    Raymond A. Kemper, Adnan A. Elfarra and Steven R. Myers
    Drug Metabolism and Disposition September 1998, 26 (9) 914-920;
  • You have access
    Covalent Sequestration of the Nitrogen Mustard Mechlorethamine by Metallothionein
    Miquel Antoine, Daniele Fabris and Catherine Fenselau
    Drug Metabolism and Disposition September 1998, 26 (9) 921-926;
  • You have access
    In Vitro and In Vivo Metabolism of Desogestrel in Several Species
    C. H. J. Verhoeven, S. F. M. Krebbers, G. N. Wagenaars and R. M. E. Vos
    Drug Metabolism and Disposition September 1998, 26 (9) 927-936;

Short Communications

  • You have access
    Pharmacokinetics and Blood-Brain Barrier Transport of an Anti-Transferrin Receptor Monoclonal Antibody (OX26) in Rats after Chronic Treatment with the Antibody
    Dafang Wu and William M. Pardridge
    Drug Metabolism and Disposition September 1998, 26 (9) 937-939;
  • You have access
    Cimetidine Sulfoxidation in Small Intestinal Microsomes
    Xiaodong Lu, Cheng Li and David Fleisher
    Drug Metabolism and Disposition September 1998, 26 (9) 940-942;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 26, Issue 9
1 Sep 1998
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • SYMPOSIUM
  • Articles
  • Short Communications
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics